Show simple item record

Time to deterioration of symptoms with durvalumab in stage III, locally advanced, unresectable NSCLC: Post-hoc analysis of PACIFIC patient-reported outcomes

dc.contributor.authorZhang, Y.
dc.contributor.authorOzguroglu, M.
dc.contributor.authorRyden, A.
dc.contributor.authorDennis, P.
dc.contributor.authorAntonia, S.
dc.contributor.authorHui, R.
dc.contributor.authorVillegas, A.
dc.contributor.authorDaniel, D.
dc.contributor.authorVicente, D.
dc.contributor.authorMurakami, S.
dc.date.accessioned2021-03-03T09:54:25Z
dc.date.available2021-03-03T09:54:25Z
dc.date.issued2018
dc.identifier.citationHui R., Ozguroglu M., Villegas A., Daniel D., Vicente D., Murakami S., Ryden A., Zhang Y., Dennis P., Antonia S., "Time to deterioration of symptoms with durvalumab in stage III, locally advanced, unresectable NSCLC: Post-hoc analysis of PACIFIC patient-reported outcomes", JOURNAL OF THORACIC ONCOLOGY, cilt.13, sa.4, 2018
dc.identifier.issn1556-0864
dc.identifier.othervv_1032021
dc.identifier.otherav_1f89dcab-13c6-4b47-8815-1c2a4bd090ad
dc.identifier.urihttp://hdl.handle.net/20.500.12627/26312
dc.identifier.urihttps://doi.org/10.1016/s1556-0864(18)30401-5
dc.language.isoeng
dc.subjectGöğüs Hastalıkları ve Allerji
dc.subjectİç Hastalıkları
dc.subjectOnkoloji
dc.subjectSağlık Bilimleri
dc.subjectDahili Tıp Bilimleri
dc.subjectTıp
dc.subjectSOLUNUM SİSTEMİ
dc.subjectKlinik Tıp (MED)
dc.subjectKlinik Tıp
dc.subjectONKOLOJİ
dc.titleTime to deterioration of symptoms with durvalumab in stage III, locally advanced, unresectable NSCLC: Post-hoc analysis of PACIFIC patient-reported outcomes
dc.typeMakale
dc.relation.journalJOURNAL OF THORACIC ONCOLOGY
dc.contributor.departmentUniversity Of Sydney , ,
dc.identifier.volume13
dc.identifier.issue4
dc.contributor.firstauthorID252669


Files in this item

FilesSizeFormatView

There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record